Literature DB >> 6333097

[Fractures in hemophilia patients].

P Markakis, N Papajoannou, G Kambouruglou.   

Abstract

The authors give a review of the most frequent forms of hemophilia and describe the problems connected with fractures in patients suffering from hemophilia, the treatment methods and the indications for conservative or surgical therapy. The evaluation of 25 cases with hemophilia treated between 1972 and 1982 for one or more fractures shows that the primary disease does not essentially influence the healing process with the understanding that an early and sufficient substitution of the missing coagulation factors is administered. By means of a correct pretreatment (infusions of plasma or coagulation factors), we have obtained good results in most of our cases.

Entities:  

Mesh:

Year:  1984        PMID: 6333097     DOI: 10.1007/bf02585724

Source DB:  PubMed          Journal:  Unfallchirurgie        ISSN: 0340-2649


  6 in total

1.  [Orthopedic problems in hemophilia. Pathophysiology and results of operations (author's transl)].

Authors:  P Hofmann; H Rössler; H H Brackmann
Journal:  Z Orthop Ihre Grenzgeb       Date:  1977-06

2.  Major surgery in haemophilia. Prolonged substitution therapy for surgical treatment of haemophilic cyst and pathological fracture of the femur.

Authors:  A L Bloom; B A Enoch; H J Richards
Journal:  Br J Surg       Date:  1968-02       Impact factor: 6.939

3.  Management of musculoskeletal problems in the hemophilias.

Authors:  J Hoskinson; R B Duthie
Journal:  Orthop Clin North Am       Date:  1978-04       Impact factor: 2.472

4.  Fractures in haemophiliacs with special reference to complications and treatment.

Authors:  A Ahlberg; I M Nilsson
Journal:  Acta Chir Scand       Date:  1967

Review 5.  [Hemophilic pseudotumors].

Authors:  P Hofmann; S Döhring; G Schumpe; K Lackner; H H Brackmann
Journal:  Z Orthop Ihre Grenzgeb       Date:  1982-04

6.  Antihemophilic factor inhibitors. Management with prothrombin complex concentrates.

Authors:  P Kelly; J A Penner
Journal:  JAMA       Date:  1976-11-01       Impact factor: 56.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.